Characterization of recurrent UMOD variants (p.C255Y y p.Q316P) in a Galician cohort: genotype-phenotype correlation and clinical implications

Q2 Medicine
Eloísa Sánchez-Cazorla , Borja Temes-Álvarez , Pilar Oliveros-Martínez , Pedro Fortes-González , María García-Murias , Ana Barcia de la Iglesia , Noa Carrera , Miguel Ángel García-González , Grupo GalERH
{"title":"Characterization of recurrent UMOD variants (p.C255Y y p.Q316P) in a Galician cohort: genotype-phenotype correlation and clinical implications","authors":"Eloísa Sánchez-Cazorla ,&nbsp;Borja Temes-Álvarez ,&nbsp;Pilar Oliveros-Martínez ,&nbsp;Pedro Fortes-González ,&nbsp;María García-Murias ,&nbsp;Ana Barcia de la Iglesia ,&nbsp;Noa Carrera ,&nbsp;Miguel Ángel García-González ,&nbsp;Grupo GalERH","doi":"10.1016/j.nefroe.2025.04.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The <em>UMOD</em> gene encodes the uromodulin protein, which plays a crucial role in renal function. Genetic alterations affecting its correct function are mainly related to Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD), progressive renal failure and hyperuricaemia, among other variable clinical phenotypes. In the Galician population there are recurrent mutations in this gene, this study aims to phenotypically characterize the recurrent variants to improve the prognosis and management strategies of affected patients.</div></div><div><h3>Methods</h3><div>In a Galician population characterized by high genetic conservation, a retrospective cohort study was conducted with 37 patients from 15 families carrying recurrent variants in <em>UMOD</em> (p.C255Y and p.Q316P, from transcript NM_001008389.3). Clinical data were collected, including renal function, hyperuricemia, hypertension and presence of renal cysts. Genomic analyses were performed by NGS and Sanger sequencing, variant classification were conducted according to ACMG guidelines. Statistical comparisons were performed using Mann-Whitney, Chi-square and Fisher tests, with Benjamini-Hochberg correction for multiple testing.</div></div><div><h3>Results</h3><div>The cohort included 28 carriers of p.C255Y and 9 of p.Q316P genetic variants. Both variants affect highly conserved domains with low tolerance to amino acid changes, which alters protein function and has clinical effects in patients. Hyperuricemia was observed in 76% of p.C255Y carriers and 50% of p.Q316P carriers, while interestingly only the first variant was associated with episodes of gout. Renal cysts and hypertension were identified in about half of the patients, independently of variant type. Kaplan–Meier curves suggested an earlier progression to hyperuricemia and advanced chronic kidney disease (CKD) in p.C255Y carriers, although without reaching statistical significance.</div></div><div><h3>Conclusions</h3><div>Recurrent <em>UMOD</em> mutations in a Galician cohort revealed shared clinical features, including hyperuricemia and CKD progression, with phenotypic variability influenced by age and additional genetic modifiers. The findings highlight the prognostic value of genotype-phenotype correlations and the need for tailored clinical management in ADTKD patients.</div></div>","PeriodicalId":31770,"journal":{"name":"Nefrologia English Edition","volume":"45 5","pages":"Pages 369-380"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nefrologia English Edition","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2013251425000586","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The UMOD gene encodes the uromodulin protein, which plays a crucial role in renal function. Genetic alterations affecting its correct function are mainly related to Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD), progressive renal failure and hyperuricaemia, among other variable clinical phenotypes. In the Galician population there are recurrent mutations in this gene, this study aims to phenotypically characterize the recurrent variants to improve the prognosis and management strategies of affected patients.

Methods

In a Galician population characterized by high genetic conservation, a retrospective cohort study was conducted with 37 patients from 15 families carrying recurrent variants in UMOD (p.C255Y and p.Q316P, from transcript NM_001008389.3). Clinical data were collected, including renal function, hyperuricemia, hypertension and presence of renal cysts. Genomic analyses were performed by NGS and Sanger sequencing, variant classification were conducted according to ACMG guidelines. Statistical comparisons were performed using Mann-Whitney, Chi-square and Fisher tests, with Benjamini-Hochberg correction for multiple testing.

Results

The cohort included 28 carriers of p.C255Y and 9 of p.Q316P genetic variants. Both variants affect highly conserved domains with low tolerance to amino acid changes, which alters protein function and has clinical effects in patients. Hyperuricemia was observed in 76% of p.C255Y carriers and 50% of p.Q316P carriers, while interestingly only the first variant was associated with episodes of gout. Renal cysts and hypertension were identified in about half of the patients, independently of variant type. Kaplan–Meier curves suggested an earlier progression to hyperuricemia and advanced chronic kidney disease (CKD) in p.C255Y carriers, although without reaching statistical significance.

Conclusions

Recurrent UMOD mutations in a Galician cohort revealed shared clinical features, including hyperuricemia and CKD progression, with phenotypic variability influenced by age and additional genetic modifiers. The findings highlight the prognostic value of genotype-phenotype correlations and the need for tailored clinical management in ADTKD patients.
加利西亚队列中复发性UMOD变异(p.C255Y y . p.Q316P)的特征:基因型-表型相关性和临床意义
背景:UMOD基因编码尿调蛋白,其在肾功能中起着至关重要的作用。影响其正确功能的遗传改变主要与常染色体显性小管间质肾病(ADTKD)、进行性肾衰竭和高尿酸血症等可变临床表型有关。在加利西亚人群中,该基因存在复发性突变,本研究旨在对复发性变异进行表型表征,以改善受影响患者的预后和管理策略。方法:在一个具有高度遗传保守性的加利西亚人群中,对来自15个家族的37名携带UMOD复发变异(p.C255Y和p.c 316p,来自转录本NM_001008389.3)的患者进行了回顾性队列研究。收集临床资料,包括肾功能、高尿酸血症、高血压和肾囊肿的存在。基因组分析采用NGS和Sanger测序,根据ACMG指南进行变异分类。统计学比较采用Mann-Whitney检验、卡方检验和Fisher检验,多项检验采用Benjamini-Hochberg校正。结果:该队列包括28名p.C255Y携带者和9名p.c 316p遗传变异携带者。这两种变异都影响高度保守的结构域,对氨基酸变化的耐受性较低,从而改变蛋白质功能,并对患者产生临床影响。在76%的p.C255Y携带者和50%的p.Q316P携带者中观察到高尿酸血症,而有趣的是,只有第一种变体与痛风发作有关。肾囊肿和高血压在大约一半的患者中被发现,独立于变异类型。Kaplan-Meier曲线提示p.C255Y携带者更早进展为高尿酸血症和晚期慢性肾脏疾病(CKD),尽管没有达到统计学意义。结论:加利西亚队列中复发性UMOD突变揭示了共同的临床特征,包括高尿酸血症和CKD进展,表型变异受年龄和其他遗传修饰因子的影响。研究结果强调了基因型-表型相关性的预后价值,以及对ADTKD患者进行定制临床管理的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nefrologia English Edition
Nefrologia English Edition Medicine-Nephrology
CiteScore
3.00
自引率
0.00%
发文量
67
审稿时长
50 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信